Skip to main content
Equibles

LKFT · Lakefront Biotherapeutics NV · Financials

Track LKFT — free

Use LKFT with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research LKFT.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$29.03 -0.34 (-1.16%)
Rebalance outlook locked
Market Cap
$1.92B
Shares
65.48M
Volume · Oct 2 270.23K Avg daily vol (3M) 253.28K

Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.

Pull these statements through the financial statements API or MCP →
Revenue
1.11B +303.5%
FY2025 Revenue FY2015–FY2025
Net Income
320.88M +333.1%
FY2025 Net Income FY2015–FY2025
Gross Margin
97.33% +10pp
FY2025 Gross Margin FY2021–FY2025
Operating Margin
26.53% +94.9pp
FY2025 Operating Margin FY2015–FY2025
Operating Cash Flow
-257.46M +19.6%
FY2025 Operating Cash Flow FY2015–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Income Statement Balance Sheet Cash Flow All Metrics
Annual Quarterly
Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018 FY2017 FY2016 FY2015
EUR 1.11B 275.65M 239.72M 241.25M 234.38M 478.05M 834.9M 278.67M 127.09M 129.52M 39.56M
EUR 29.74M 34.86M — 12.08M 1.63M — — — — — —
EUR 459.42M 335.46M 241.29M 269.8M 320.5M 523.67M 420.09M 316.22M 218.5M 139.57M 129.71M
EUR 6.1M 17.19M 5.68M 3.48M 3.78M 66.47M 24.58M 4.15M 2.8M 1.79M 1.18M
EUR 147.33M 117.25M 128.29M 135.16M 127.74M 118.76M 72.38M 34.38M 24.42M 21.74M 19.13M
EUR — — — — — — — — 3.63M 3.32M 2.37M
EUR 295.04M -188.34M -88.26M -131.06M -171.57M -178.63M 368.75M -47.08M -89.8M -11.49M -89.44M
EUR 300.87M -3.09M 5.63M -70.85M -119.4M -309.78M 148.53M -31.42M -115.51M 54.25M -119.63M
EUR -18.62M -1.8M 9.61M 572K 1.39M 1.23M -165K 822K 198K 235K -1.22M
EUR 320.88M 74.08M 211.7M -217.99M -103.23M -305.44M 149.85M -29.26M -115.7M 54.01M -118.41M
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Lease liabilities 2025-12-31 EUR 6,915,000 20-F filed 2026-03-26
Related accounting measures — not additional borrowing

Carrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year.

Current lease liabilities
EUR 1,729,000
Noncurrent lease liabilities
EUR 5,186,000
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.

Key facts CIK 1421876 CUSIP 36315X101 13F (30d) 2 filings 2 filers Visit website Investor relations